Flick Matthew, Martinez Casey, Fipps David C
Mayo Clinic Alix School of Medicine, Mayo Clinic Arizona, Scottsdale, Arizona, USA.
Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, USA.
Case Rep Psychiatry. 2025 Mar 18;2025:6621450. doi: 10.1155/crps/6621450. eCollection 2025.
Rastafarianism maintains that cannabis is a sacred element of the religious practice, and followers of the religion traditionally engage cautiously with western medicine. This case involves Mr. I, a 72-year-old Rastafari male with acute myelogenous leukemia (AML) and hepatic decompensation, who developed delirium with psychotic features which were initially managed with quetiapine. His family expressed concerns with psychotropic medications and requested using dronabinol, a synthetic cannabinoid, to manage his symptoms considering the spiritual significance of cannabinoids in the Rastafari culture. The psychiatry team's dissenting recommendations regarding dronabinol was met with resistance, and the family voiced that they felt their religious beliefs were not being respected and considered bringing in their own marijuana products. Following an ethics consultation, a compromise was reached to trial low-dose dronabinol. However, Mr. I's symptoms worsened, prompting discontinuation of dronabinol and management with olanzapine. This case exemplifies the complexities of clinical care when religious beliefs conflict with medical necessity. We discuss the limited indications for dronabinol and potential adverse effects on delirium's behavioral symptoms. Concerns about fungal sensitization from cannabinoid products in the context of immunosuppressive chemotherapy and the effects of cannabinoids on hepatic dysfunction are also explored. Moreover, we emphasize the importance of cultural sensitivity for Rastafari individuals who view marijuana as sacred and therapeutic. Balancing cultural and religious sensitivity with ethical, evidence-based medicine through a thorough discussion of risks and benefits is essential for optimal decision-making in such ethical dilemmas.
拉斯塔法里运动认为大麻是宗教仪式中的神圣元素,该宗教的信徒传统上对西医持谨慎态度。本案例涉及一位72岁的拉斯塔法里男性I先生,他患有急性髓系白血病(AML)和肝代偿失调,出现了伴有精神病特征的谵妄,最初使用喹硫平进行治疗。他的家人对精神药物表示担忧,并考虑到大麻素在拉斯塔法里文化中的精神意义,请求使用合成大麻素屈大麻酚来控制他的症状。精神科团队对屈大麻酚的不同建议遭到了抵制,家人表示他们觉得自己的宗教信仰没有得到尊重,并考虑引入他们自己的大麻产品。经过伦理咨询后,达成了一项妥协方案,即试用低剂量的屈大麻酚。然而,I先生的症状恶化,促使停用屈大麻酚并改用奥氮平进行治疗。这个案例体现了宗教信仰与医疗必要性相冲突时临床护理的复杂性。我们讨论了屈大麻酚的有限适应症以及对谵妄行为症状的潜在不良影响。还探讨了在免疫抑制化疗背景下大麻素产品引起真菌致敏的问题以及大麻素对肝功能障碍的影响。此外,我们强调了对将大麻视为神圣和具有治疗作用来看待的拉斯塔法里个体具有文化敏感性的重要性。通过对风险和益处进行全面讨论,在文化和宗教敏感性与符合伦理的循证医学之间取得平衡,对于在此类伦理困境中做出最佳决策至关重要。